![Serotonin-norepinephrine reuptake inhibitors / Research / Amines / Cyclopropanes / Milnacipran / European Medicines Agency / Electronic patient-reported outcome / Antidepressant / Fibromyalgia / Chemistry / Clinical research / Health Serotonin-norepinephrine reuptake inhibitors / Research / Amines / Cyclopropanes / Milnacipran / European Medicines Agency / Electronic patient-reported outcome / Antidepressant / Fibromyalgia / Chemistry / Clinical research / Health](https://www.pdfsearch.io/img/fa36ad3f508de0feacb247e46e765632.jpg)
| Document Date: 2013-07-21 06:02:35 Open Document File Size: 607,53 KBShare Result on Facebook
City London / / Company CHMP Scientific Advisory Group / / / Facility Canary Wharf / / / IndustryTerm food effect / treatment of Fibromyalgia syndrome / defined products / manufacturing overages / pharmaceutical and biological aspects / pharmaceutical development / pharmaceutical excipients / chosen manufacturing process / medicinal product / food contact requirements / Physical and chemical characteristics / treatment of fibromyalgia / a disorder / degradation products / drug products / manufacturing process / / MedicalCondition blisters / convulsions / aluminum blister / disease / fibromyalgia / chronic pain / Fibromyalgia syndrome / chronic musculoskeletal pain / pain / fatigue / disorder / chronic pain models / PVC/ACLAR/Al blisters / sleep disorders / chronic rheumatological disorder / / MedicalTreatment intravenous infusion / / Organization European Medicines Agency / European Union / / Person Gonzalo Calvo / Ian Hudson / Pierre Fabre / Pierre Fabre Médicament / Martin Votava / / / Product talc / epinephrine / / ProgrammingLanguage EC / C / / ProvinceOrState Nebraska / / Technology X-ray / API / pharmacodynamics / process control / / URL http /
SocialTag |